A Study of LY3841136 in Overweight and Obese Participants

Clinical trial NCT06345066 · COMPLETED

Trial details

NCT number: NCT06345066
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2024-04-03
Primary completion: 2025-09-29
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.